Drug recall · February 14, 2018
Linezolid Injection 600 mg/300 mL recall
Why: Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51
- Lots / codes
Lot # CLZ160007, Exp August 2018
- Quantity
- 9,050 bags
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Product was distributed throughout United States.
- Initiated
- December 20, 2017 · Voluntary: Firm initiated
- Classified
- February 8, 2018
- Reported
- February 14, 2018
- Ended
- June 24, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Linezolid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.